Chef Joey Maggiore, his family, and the teams at The Mexicano in Phoenix and The Italiano in Scottsdale are launching a ...
Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...
Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPCInitiating ...
The Fellows of the AACR Academy have elected Elaine V. Fuchs, PhD, FAACR, as their next President. She will assume the ...
Cardiac and major vascular surgeries are intricate and high-risk procedures known for significant morbidity and mortality ...
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
HealthDay on MSN5 天
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DMGLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...
In this video, John O. Mascarenhas, MD, professor of medicine at the Icahn School of Medicine, discussed recent developments and emerging treatments in myeloproliferative neoplasms care.
Appendix tumors should be evaluated separately and not included in colon or colorectal cancer categories,” researchers concluded.
Treatment guidelines in polycythemia vera currently recommend maintaining hematocrit below 45%, with a higher threshold for ...
Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced positive results from the VERIFI study, the second clinical validation study of its next-generation ...
Labor Dr. Wisplinghoff will offer GTC's next-generation sequencing-based tests for solid tumor and hematologic neoplasms.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果